PMID- 18003766 OWN - NLM STAT- MEDLINE DCOM- 20080130 LR - 20231024 IS - 1555-905X (Electronic) IS - 1555-9041 (Linking) VI - 3 IP - 1 DP - 2008 Jan TI - N-acetylcysteine in the prevention of contrast-induced nephropathy. PG - 281-7 AB - BACKGROUND AND OBJECTIVES: Contrast-induced nephropathy (CIN) is a common clinical problem that is growing in importance as an increasing number of tests and procedures that utilize contrast media are performed. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: The biological and pharmacological properties of n-acetylcysteine (NAC) are reviewed, as well as the current literature relevant to the ability of NAC to prevent CIN. RESULTS: After publication of a seminal study by Tepel et al. in 2000, there has been a surge in interest regarding the ability of NAC to reduce the risk for CIN. Since then a large number of studies, mostly with relatively small sample sizes, have been published. CONCLUSIONS: The results have been remarkably varied with some studies finding great efficacy with NAC but most finding no significant benefit. FAU - Fishbane, Steven AU - Fishbane S AD - Winthrop-University Hospital, Mineola, New York 11501, USA. sfishbane@winthrop.org LA - eng PT - Journal Article PT - Review DEP - 20071114 PL - United States TA - Clin J Am Soc Nephrol JT - Clinical journal of the American Society of Nephrology : CJASN JID - 101271570 RN - 0 (Contrast Media) RN - 0 (Free Radical Scavengers) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM MH - Acetylcysteine/chemistry/*therapeutic use MH - Acute Kidney Injury/*chemically induced/*prevention & control MH - Contrast Media/*adverse effects MH - Free Radical Scavengers/chemistry/*therapeutic use MH - Humans RF - 80 EDAT- 2007/11/16 09:00 MHDA- 2008/01/31 09:00 CRDT- 2007/11/16 09:00 PHST- 2007/11/16 09:00 [pubmed] PHST- 2008/01/31 09:00 [medline] PHST- 2007/11/16 09:00 [entrez] AID - CJN.02590607 [pii] AID - 10.2215/CJN.02590607 [doi] PST - ppublish SO - Clin J Am Soc Nephrol. 2008 Jan;3(1):281-7. doi: 10.2215/CJN.02590607. Epub 2007 Nov 14.